← Every company
Madrigal Pharmaceuticals Inc Planned Sales
Before an insider at Madrigal Pharmaceuticals Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
MDGL insider trades →Notices on file
2
Insiders
2
Shares noticed
55.2K
permission to sell, not sales
Estimated value
$28.6M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Friedman PaulDirector2026-09-2850K sh0.22% | $25.8M |
| Sibold WilliamDirector, Officer2026-09-115.2K sh0.02% | $2.8M |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on MDGL
Company overviewEverything on MDGL in one place, with the price.SEC filingsWhat MDGL's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat MDGL's own officers and directors buy and sell.Who owns itEvery manager reporting a position in MDGL.Funds holding itWhich funds and ETFs hold MDGL, and how big a bet.LobbyingWhat MDGL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on MDGL's account, and who they worked for.Federal contractsWhat federal agencies pay MDGL.PatentsWhat MDGL is filing at the patent office.